U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07252427) titled 'Gut Microbiota in IBD With Comorbid Depressive Disorder' on Nov. 16.
Brief Summary: Inflammatory bowel disease (IBD) is often comorbid with depressive disorder, and the development and progression of both conditions are closely related to the composition of gut microbiota and metabolites. However, studies investigating their comorbidity using microbiome and metabolomics approaches remain limited.
This study aims to investigate the diversity changes in the gut microbiome and metabolome of patients with comorbid IBD and depressive disorder through multi-omics approaches, to identify specific microbial and metabolic signatures associa...